California Cancer Reporting System Standards, Volume III

IF1179: TNM Clin Stage Group, SSF 2 Lymphoma (COC)

OWNER

CoC

EDIT SETS

California Hospital Transmit

Eureka Admission Level

Eureka Tumor Level

FIELDS

TNM Clin Stage Group [NAACCR #970]

CS Site-Specific Factor 2 [NAACCR #2890]

Date of Diagnosis [NAACCR #390]

Histologic Type ICD-O-3 [NAACCR #522]

Primary Site [NAACCR #400]

Type of Reporting Source [NAACCR# 500]

Behavior Code ICD-O-3 [NAACCR# 523]

TABLE

N/A

MESSAGE

  1. IF1179: TNM Clin Stage Group [value] and CS Site-Specific Factor 2 [value] conflict

specification

Purpose: This edit verifies that TNM Clin Stage and CS SSF 2, Systemic Symptoms at Diagnosis, are coded consistently for lymphoma.

 

This edit is skipped if any of the following conditions are true:

  1. Year of Date of Diagnosis is less than 2016, blank (unknown), or invalid

  2. Type of Reporting Source = 7 (Death Certificate Only)

  3. Behavior Code ICD-O-3 = 0 (benign) or 1 (borderline)

  4. TNM Clin Stage Group is blank

  5. CS Site-Specific Factor 2 is blank or 988

  6. TNM Edition Number not = 07, U7

 

The edit is evaluated for site/histology groups 57A and 57C.  The site/histology groups are identified by site and histology in the edit Primary Site, AJCC Stage Group 2016 - Ed 7 (COC), Primary Site, Stage Group 2016 - Ed 7 (NPCR), and Primary Site, Stage Group 2016 - Ed 7 (SEER).

 

  1. If TNM Clin Stage Group = 1A, 2A, 3A, or 4A, then CS SSF 2 must = 000 (No B symptoms) or 020 (Pruritis)

  2. If TNM Clin Stage Group = 1B, 2B, 3B, or 4B, then CS SSF 2 must = 010 (any B symptoms) or 030 (any B symptoms + pruritis)

  3. If TNM Clin Stage Group = 1, 2, 3, or 4, then CS SSF 2 must = 999 (unknown or no information)

historical changes

In the SEER*Edits software, the title of this edit is: IF621.

08/2016

Per NAACCR v16, new edit added.

09/2016

Per NAACCR v16A, corrected Description and Edit Logic to include 9727 as lymphoma rather than lymphoma/leukemia code.

11/2016

Per NAACCR v16B:

  • Description updated to reference 3 edits where site/histology groups are identified: Primary Site, AJCC Stage Group 2016 - Ed 7 (COC), Primary Site, Stage Group 2016 - Ed 7 (NPCR), and Primary Site, Stage Group 2016 - Ed 7 (SEER).

  • Description and Edit Logic updated to include checks for stage groups 4, 4A, and 4B against CS-Site-Specific Factor 2 for histologies 9811-9818, 9837 with primary sites C420, C421, and C424, site/histology group 57C.  These site/histologies can be coded as either hematopoietic or lymphoid malignancy according to agreement reached between SEER and COC.

03/2017

Per NAACCR v16D:

  • Added skip if TNM Edition Number not = 07,U7.

  • SEER IF261 in modification for NAACCR v16A changed to SEER IF621.